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Abstract 
Purpose: To investigate and compare the trends in incidence and mortality of penile cancer between Australia, Eng-
land and Wales, and the US, and provide hypotheses for these trends.
Methods: Cancer registry data from 1982 to 2005 inclusive were obtained from Australia, England and Wales, and 
the United States. From these data, age-specific, -standardised and mortality:incidence ratios were calculated, and 
compared.
Results: The overall incidence of penile cancer in England and Wales (1.44 per 100,000 man-years) was higher than 
in Australia (0.80 per 100,000), and the US (0.66 per 100,000). Incidence of penile cancer in all three countries has 
remained relatively stable over time. Similarly, although the mortality rates were also higher in England and Wales 
(0.37 per 100,000 man-years) compared to Australia (0.18 per 100,000) and the US (0.15 per 100,000), the mortality/
incidence ratios were similar for all three countries.
Conclusions: Penile cancer incidence is low, affecting mainly older men. Rates differ between the three countries, 
being twice as common in England and Wales as in the other studied regions. Circumcision rates have a potential 
influence on these rates but are not the sole explanation for the variation.
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Background
Invasive squamous cell carcinoma of the penis (hereafter 
referred to as penile cancer) is a rare disease, the reported 
rates of which vary widely between countries (Parkin and 
Muir 1992). Penile cancer predominantly affects older 
men, but is a disease that carries with it a high psycho-
logical impact of treatment. Although penile preserving 
surgery is becoming increasingly common, partial or 
total penectomy is sometimes required, in addition to 
potential chemoradiotherapy for patients with advanced 
nodal disease.
Multiple causative factors for penile cancer have been 
identified, mostly relating to inflammation of the penis, 
although cigarette smoking and low socioeconomic sta-
tus have also been linked to the disease (Dillner et  al. 
2000; Tsen et al. 2001; Madsen et al. 2008; Maden et al. 
1993; Aynaud et  al. 1999; Narayana et  al. 1982; Daling 
et  al. 2005). In particular, the association between phi-
mosis and penile cancer has been well studied, and a 
causal link between the two conditions is widely accepted 
(Larke et al. 2011; Pizzocaro et al. 2010). A link between 
infant circumcision and penile cancer has been drawn, 
with a degree of controversy in the literature as some 
advocate infant circumcision as preventative of penile 
cancer (Dodge et  al. 1963; Morris et  al. 2012; Svoboda 
and Van Howe 2013).
Here we compare the incidence and mortality of penile 
cancer over a number of years, between Australia, the US 
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and England and Wales, three Western countries with 
broadly similar populations. We also discuss causative 
factors for the disease and look in further depth at cir-
cumcision, comparing rates of circumcision between the 
three countries to identify if there is an impact on the 
incidence of penile cancer.
Methods
Data regarding penile cancer diagnoses and mortality 
from 1982 to 2005 were obtained from the Australian 
Institute of Health and Welfare National Mortality Data-
base, the England and Wales Cancer Registry, and from 
the Surveillance, Epidemiology, and End Results (SEER) 
Registries in the US. The penile cancer diagnoses for the 
UK were available only from 1995 to 2003, however mor-
tality data was available from 1982–2005. Nine registries 
were used when analysing the SEER database (Atlanta, 
Connecticut, Detroit, Hawaii, Iowa, New Mexico, San 
Francisco-Oakland, Seattle-Puget Sound, and Utah).
The Australian Institute of Health and Welfare (AIHW) 
database is the central cancer registry for all cancer inci-
dence and deaths and collates data by all state-based can-
cer registries in Australia and is a validated and reputable 
source of data (Australian Institute of Health and Welfare 
2012). Similarly, the England and Wales Cancer Regis-
try and SEER database are also previously validated and 
reputable cancer registry databases in England (Office 
of National Statistics 2014) and the US (National Cancer 
Institute 2010), respectively.
Statistics
Age-specific rates were calculated using 5-year age 
groups capped with an 85  +  group and age-standard-
ised incidences were calculated using the Segi World 
Standard Population (Segi et al. 1957). For the incidence 
trends, crude incidence was calculated, as age-specific 
incidence was not available for each year covered.
Mortality rates were calculated per 100,000 man-years 
and mortality/incidence ratios were calculated using 
crude incidence and mortality rates.
Incidence rates were calculated for 1- and 5-year peri-
ods and incidence trends were calculated using linear 
regression. Statistics were calculated using one-way 
ANOVA. Standard error is displayed on figures where 
applicable.
Statistics were calculated using Microsoft Excel, ver-
sion 14.1 for Mac OSX (2011).
Literature review
To investigate the prevalence of circumcision, a literature 
search was performed using the pubmed database with 
the MeSH terms “circumcision” and “prevalence” AND/
OR “incidence”. Papers relevant to the 3 countries being 
studied were selected and reviewed. Twenty-three arti-
cles were reviewed. To ensure relevant papers were not 
missed, the references of the papers were also reviewed. 
Ten articles met the search criteria. Non-English articles 
were excluded.
Results
The incidence of penile cancer increases with age. (Fig. 1) 
In England and Wales and the US, the peak incidence is 
in the 85+  age group, while in Australia the incidence 
peaks in the 80–84 age group.
Data on incidence of penile cancer were available 
between 1982 and 2005 in Australia and the US, but 
only for 1995 to 2003 in England and Wales (Fig.  2). 
The incidence in England and Wales was signifi-
cantly higher than the incidence in Australia and the 
US (p  <  0.001). Age-standardised incidence was 0.54 
in Australia, 0.52 in the US, and 0.87 in England and 
Wales (Table 1).
Mortality rates were available between 1982 and 2005 
in all studied regions (Fig. 3). Mortality is higher in Eng-
land and Wales than in Australia or the US (p < 0.001). 
Mortality/incidence (MI) rates were similar in all studied 
regions (p = 0.02) (Table 1).
Incidence trends were calculated using linear regres-
sion, and proved stable in England and Wales and in the 
US. A very small but statistically significant increase was 
observed in the Australian data (0.7% per year, p = 0.006) 
(Table 1).
Discussion
The data we present here clearly show a significant dif-
ference between the incidence of penile cancer in the 
US, England and Wales, and Australia. While the US 
and Australian incidences are similar, the incidence in 
England and Wales is considerably higher. The rates in 
England and Wales correlate with other published Euro-
pean data; rates in Denmark are similarly high (1.3 per 
100,000 man-years) (Baldur-Felskov et al. 2012). Of note, 
the MI indices of all three countries are similar, suggest-
ing that the treatment and stage of diagnosis of the can-
cers in all three countries are similar. The incidences of 
penile cancer in all three studied areas are much lower 
than the published rates from Africa. The peak in age-
specific incidence varied between Australia, the US and 
England and Wales, peaking in the 80–84 age group in 
Australia and the 85+ age group in the US and England 
and Wales.
Trends in incidence show that the rates of penile cancer 
were stable over the studied period in England and Wales 
and the US. The Australian data show a very small but 
statistically significant increase over time. The fact that 
there has been little change in penile cancer incidence 
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over time suggests that either the aetiological factors are 
unchanging or that despite changes in individual factors, 
the overall balance of protective and causative factors has 
been maintained.
The Australian and British populations are broadly 
similar in their rates of many cancers, with the notable 
exception of sun-related skin cancers (Parkin 2001; Soci-

































































































































Fig. 2 Incidence of penile cancer in three countries by year, per 100,000 man-years.
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two countries, the diet, and the lifestyles are also similar, 
meaning that genetic or broad lifestyle factors are less to 
account for this difference in incidence (Dwyer and Het-
zel 1980). Various aetiological factors are proposed to play 
a role in penile cancer. These generally relate to inflamma-
tory processes that occur in the penis, and include HPV 
infection, phimosis, lichen sclerosus, and poor penile 
hygiene (Dillner et al. 2000; Tsen et al. 2001; Madsen et al. 
2008; Maden et  al. 1993; Aynaud et  al. 1999; Narayana 
et al. 1982; Daling et al. 2005). It seems unlikely that there 
is a significant and persistent difference in penile hygiene 
between England and Wales and Australia, so this is 
unlikely to account for the difference in incidence.
Smoking rates have been declining since at least the 
1980s, in all three regions (Ng et al. 2014). The rates are 
similar in each region, meaning that difference in smok-
ing rates is unlikely to account for a difference in penile 
cancer rates (West et al. 2007; Jha et al. 2002).
Little data has been published about incidence trends 
for HPV infection, especially in males. A study from Fin-
land, where large serum banks have been collected for 
many years, suggest increasing rates of HPV infection 
between the 1980s and 1990s, in women of childbear-
ing age (Laukkanen et  al. 2003). Due to widely vary-
ing prevalence of HPV infection around the world, this 
may not hold true in the countries studied in this paper 
Table 1 5-year incidence, mortality, and mortality/incidence ratios and incidence trends
Incidence data only available for England and Wales from 1995–2003.
5-year incidence Mortality rates M/I ratio Incidence trend
Year AUS US E&W AUS US E&W AUS US E&W AUS US E&W
1984–88 0.55 0.70 – 0.19 0.16 0.42 0.36 0.32 – – – –
1989–93 0.59 0.62 – 0.20 0.16 0.40 0.33 0.33 – 7.0% −10.9% –
1994–98 0.67 0.59 1.21 0.16 0.15 0.35 0.23 0.35 0.25 14.0% −4.9% –
1999–2003 0.72 0.69 1.29 0.17 0.15 0.35 0.24 0.30 0.24 7.4% 15.7% 6.4%
2004–05 0.65 0.58 – 0.13 0.15 0.30 0.20 0.34 – −10.9% −15.2% –
ANOVA p < 0.001 p < 0.001 p = 0.02 Trend by linear regression (p-value)






































































Fig. 3 Mortality rates in 3 countries by year, per 100,000 man-years. Note: standard error not displayed on Australian data as cases per year not 
available.
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(Clifford et al. 2005). With HPV vaccination programmes 
becoming widespread, it is likely that these rates are fall-
ing. Nevertheless, given the long lag time between HPV 
infection and penile cancer developing, no effect is likely 
to be seen for many years to come, and this is therefore 
unlikely to have affected the results of this study.
A link has been drawn between a lack of neonatal/
infant circumcision and an increase incidence of penile 
cancer. It has been suggested that infant circumci-
sion rather than adult circumcision reduces the risk of 
penile cancer (Maden et al. 1993; Larke et al. 2011; Sch-
oen et  al. 2000). A meta-analysis by Larke et  al. (2011) 
shows an odds ratio of 0.33 for penile cancer in patients 
who underwent infant circumcision. Much of the early 
literature concerning the link between penile cancer 
and circumcision has come from studies conducted in 
the US and Africa, where different cultural groups rou-
tinely perform infant circumcision, and are noted to 
have lower incidence of penile cancer (Dodge et al. 1963; 
Wolbarst 1932). However, the findings from Africa may 
not be directly applicable to a Western setting, given that 
recorded incidences of penile cancer in African countries 
are much higher than the global average (Wabinga et al. 
2000; Parkin et al. 2008). Despite this, various organisa-
tions have published position papers and recommenda-
tions regarding infant circumcision, often mentioning 
an association with penile cancer, but the topic remains 
under debate (WHO/UNAIDS technical consultation 
2007; Fetus and Newborn Committee, Canadian Paediat-
ric Society 1996; American Academy of Pediatrics 1999; 
Lannon et al. 2000).
To investigate whether circumcision rates could be 
having an impact on our data, we conducted a review of 
the available literature regarding circumcision rates. Lim-
ited data have been published regarding circumcision 
rates, but those data which were available is summarised 
in Table  2. The data available were a mix of population 
prevalence and yearly incidence, with many of the inci-
dence data being in-hospital neonatal/infant circumci-
sion rates. As the vast majority of circumcisions occur 
in infancy, incidence rates should roughly correlate 
with prevalence of circumcision (i.e.: if 10% of the male 
population are circumcised in infancy, then it would be 
expected that 10% of the population at a given point in 
time would be circumcised). Some prevalence data come 
from cross-sectional studies or surveys, and other data 
represent expert estimation.
The US and Australia had the highest prevalence and 
incidence rates, with prevalence in Australia 30–50%, 
and incidence of infant circumcision 10–20%. Prevalence 
in the US was 79% and incidence of infant circumcision 
55–60%. The UK had much lower circumcision rates than 
the other two countries, with 15–20% prevalence and an 
incidence of just 3–4% infant circumcision. Data on Eng-
land and Wales alone, separating out the rest of the UK, 
were not available. The fact that incidence in all cases 
was lower than prevalence is likely due to two factors: 
(1) reporting of only a subset of circumcisions (infant 
in-hospital), and discounting religious/cultural circumci-
sions that occur outside hospital, as well as adult circum-
cisions, and, (2) falling rates of circumcision. Infant and 
adult circumcision typically occur for different reasons. 
There is good inter-study correlation for each of the three 
countries. However, the studies cannot be aggregated 
in their results as different methods have been used to 
obtain values for incidence and prevalence.
As has been previously noted, infant circumcision has 
been posited to have a protective role in penile cancer 
(Maden et  al. 1993; Larke et  al. 2011; Pizzocaro et  al. 
2010). The rates of infant circumcision are widely differ-
ent between Australia and the UK, which have broadly 
similar populations. The differing incidence of penile 
Table 2 Circumcision rates in Australia, the UK, and the US
Country Author Year Circumcision prevalence/incidence
Australia Richters et al. (2006) 2002 59% (prevalence in 16–19 year olds only 31%)
Australia Spilsbury et al. (2003) 1994–1999 8–10% infant circumcision
Australia RACP, Division of Infant and Child Health (2010) 2010 10–20% infant circumcision (estimated)
Australia Darby (2011) 2000–2010 12% neonatal circumcision
UK Gairdner (1949) 1949 20% (estimated)
UK Dave et al. (2003) 2000 15.8% (prevalence in 16–19 year olds 11.7%)
UK Rickwood et al. (2000) 2000 3.8% (circumcision before 15)
UK Cathcart et al. (2006) 1997–2003 3.9%, with 3.1% circumcision before 15
US American Academy of Paediatrics (2012) 1998–2008 57% infant circumcision
US American Academy of Paediatrics (2012) 1999–2004 79% prevalence
US Centers for Disease Control (2011) 1999–2010 55.8–59.1% infant circumcision
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cancer between the two populations may therefore 
reflect the protective effect of neonatal circumcision in 
Australia.
The circumcision rates in the US are much higher 
than the rates in the other two countries. Although the 
population demographics and rates of other cancers in 
the US differ from the other two countries, the incidence 
of penile cancer is similar to that in Australia (Parkin 
and Muir 1992; Parkin 2001). It might be expected that 
if a strong protective effect of infant circumcision were 
present, incidence of penile cancer in the US would be 
considerably lower than in the other countries. However, 
this lack of difference is difficult to interpret, given the 
many demographic differences between the US popu-
lation and the other two studied countries. A recent 
paper using in-depth analysis of the SEER nine registries 
between 1973 and 2002 found that the penile cancer rate 
was far higher in Hispanic whites than in other popula-
tion groups within the US (Barnholtz-Sloan et al. 2007). 
This is a group that is not highly represented in either 
England and Wales or Australia, and this may obscure 
the interaction between circumcision rates and penile 
cancer incidence when the three regions are compared. 
It would be interesting to examine circumcision rates in 
this population for comparison with other populations 
in the US. However, these data were not available for this 
study.
Although we see only a tiny rise in penile cancer rates 
in Australia, and no statistically significant change in inci-
dence in England and Wales as the rate of circumcision 
has fallen, it is entirely possible that this is due to the long 
lag between infant circumcision and the peak incidence 
of penile cancer. Over time, mortality from penile cancer 
has marginally reduced, presumably with improved treat-
ment, possibly in assessing for and managing early nodal 
disease. With a generally noted decline in circumcision 
rates beginning in 1950 and continuing until the present, 
were a distinct correlation in penile cancer incidence to 
emerge, it would be likely to begin to be observed in 2020 
and trend upwards until 2060.
Limitations from this study include the fact that the 
use of cancer registry databases, which, while widely 
accepted, relies on reporting of cancer, either when diag-
nosed or on a death certificate. This may result in under-
reporting of disease rates.
Conclusion
Penile cancer is a rare disease, the burden of which falls 
predominantly on older males. The rates have remained 
fairly stable between 1982 and 2005 in all three regions. 
In addition, mortality/incidence ratios were similar 
across all three regions, suggesting similar treatment 
outcomes.
England and Wales had the highest incidence and mor-
tality rates of penile cancer compared to Australia and US 
and also the lowest infant circumcision rates and over-
all circumcision prevalence. This offers some support to 
previous data suggesting infant circumcision may reduce 
risk of penile cancer. However, despite having higher cir-
cumcision rates in the US, the incidence of penile cancer 
in Australia and the US were similar, suggesting that the 
penile cancer incidence is not solely attributable to cir-
cumcision rates.
It will be interesting to observe the trends in the inci-
dence of penile cancer over the years to come, as the time 
interval between change in infant circumcision rates and 
development of penile cancer grows.
Authors’ contribution
BA—Project Development, data collection, data analysis, manuscript editing, 
supervision. DDS—data collection, data analysis, manuscript editing. LH—
data analysis, manuscript editing. RP—project development, manuscript edit-
ing, supervision. TR—project development. WR—project development, data 
collection, data analysis, manuscript editing. JS—project development, data 
collection, data analysis, manuscript preparation. JV—data analysis, manu-
script editing, supervision. All authors read and approved the final manuscript.
Author details
1 Department of Surgery, Western Hospital, Gordon Street, Footscray, VIC 3011, 
Australia. 2 Monash Health, Melbourne, Australia. 3 La Trobe Business School, 
La Trobe University, Melbourne, Australia. 4 St George’s Hospital, London, 
UK. 5 Department of Neurology, West Virginia University, Morgantown, USA. 
6 South West Knowledge and Intelligence Team, Public Health England, Bristol, 
UK. 7 University Hospital Bristol, Bristol, UK. 
Acknowledgements
We would like to thank Dr Mark Short, Senior Data Analyst, Cancer and Screen-
ing Unit, Australian Institute of Health and Welfare for the Australian Penile 
cancer data.
Novelty and impact
This is the first paper to compare the incidence and mortality in three regions 
of the developed world with similar populations. Previous studies looking at 
incidence of penile cancer have predominantly been focused on single coun-
tries. This is also the first paper to correlate population-based circumcision 
rates between regions of the developed world. This provides new information 
to further explore the widely-debated topic of the impact of circumcision on 
rates of penile cancer.
Compliance with ethical guidelines
Competing interests
The authors declare that they have no competing interests.
Ethics statement 
The authors affirm that this manuscript does not contain any patient data.
Received: 28 November 2014   Accepted: 29 July 2015
References
American Academy of Pediatrics (1999) Circumcision policy statement. Task 
force on circumcision. Pediatrics 103:686–693
American Academy of Pediatrics (2012) Task Force on C. Male circumcision. 
Pediatrics 130:e756–e785
Page 7 of 7Sewell et al. SpringerPlus  (2015) 4:420 
Australian Institute of Health and Welfare (2012) Canberra. http://www.aihw.
gov.au/index.cfm. Accessed 11 May 2014
Aynaud O, Piron D, Bijaoui G, Casanova JM (1999) Developmental factors of 
urethral human papillomavirus lesions: correlation with circumcision. BJU 
Int 84:57–60
Baldur-Felskov B, Hannibal CG, Munk C, Kjaer SK (2012) Increased incidence of 
penile cancer and high-grade penile intraepithelial neoplasia in Denmark 
1978–2008: a nationwide population-based study. Cancer Causes Control 
CCC 23:273–280
Barnholtz-Sloan JS, Maldonado JL, Pow-sang J, Guiliano AR (2007) Incidence 
trends in primary malignant penile cancer. Urol Oncol Semin Orig Inves-
tig 25:361–367
Cathcart P, Nuttall M, van der Meulen J, Emberton M, Kenny SE (2006) Trends in 
paediatric circumcision and its complications in England between 1997 
and 2003. Br J Surg 93:885–890
Centers for Disease Control, Prevention (2011) Trends in in-hospital newborn 
male circumcision–United States, 1999–2010. MMWR Morb Mortal Wkly 
Rep 60:1167–1168
Clifford GM, Gallus S, Herrero R, Munoz N, Snijders PJ, Vaccarella S et al (2005) 
Worldwide distribution of human papillomavirus types in cytologically 
normal women in the International Agency for Research on Cancer HPV 
prevalence surveys: a pooled analysis. Lancet 366:991–998
Daling JR, Madeleine MM, Johnson LG, Schwartz SM, Shera KA, Wurscher MA 
et al (2005) Penile cancer: importance of circumcision, human papil-
lomavirus and smoking in in situ and invasive disease. Int J Cancer J Int 
Cancer 116:606–616
Darby R (2011) Infant circumcision in Australia: a preliminary estimate, 2000-
10. Aust NZ J Public Health 35:391–392
Dave SS, Fenton KA, Mercer CH, Erens B, Wellings K, Johnson AM (2003) Male 
circumcision in Britain: findings from a national probability sample 
survey. Sex Transm Infect 79:499–500
Dillner J, von Krogh G, Horenblas S, Meijer CJ (2000) Etiology of squamous cell 
carcinoma of the penis. Scand J Urol Nephrol Suppl 34(205):189–193
Dodge OG, Linsell CA, Davies JN (1963) Circumcision and the incidence of 
carcinoma of the penis and the cervix. a study in Kenya and Uganda 
Africans. East Afr Med J 40:440–444
Dwyer T, Hetzel BS (1980) A comparison of trends of coronary heart disease 
mortality in Australia, USA and England and Wales with reference to 
three major risk factors-hypertension, cigarette smoking and diet. Int J 
Epidemiol 9:65–71
Fetus and Newborn Committee, Canadian Paediatric Society (1996) Neo-
natal circumcision revisited. CMAJ Can Med Assoc J J Assoc Med can 
154:769–780
Gairdner D (1949) Fate of the foreskin. Br Med J 2(4642):1433
Jha P, Ranson MK, Nguyen SN, Yach D (2002) Estimates of global and regional 
smoking prevalence in 1995, by age and sex. Am J Public Health 
92:1002–1006
Lannon CM, Bailey A, Fleischman A, Shoemaker C, Swanson J (2000) Cir-
cumcision debate. Task force on circumcision, 1999–2000. Pediatrics 
105:641–642
Larke NL, Thomas SL, dos Santos Silva I, Weiss HA (2011) Male circumcision 
and penile cancer: a systematic review and meta-analysis. Cancer Cause 
Control CCC 22:1097–1110
Laukkanen P, Koskela P, Pukkala E, Dillner J, Laara E, Knekt P et al (2003) Time 
trends in incidence and prevalence of human papillomavirus type 6, 11 
and 16 infections in Finland. J Gener Virol 84:2105–2109
Maden C, Sherman KJ, Beckmann AM, Hislop TG, Teh CZ, Ashley RL et al (1993) 
History of circumcision, medical conditions, and sexual activity and risk of 
penile cancer. J Natl Cancer Inst 85:19–24
Madsen BS, van den Brule AJ, Jensen HL, Wohlfahrt J, Frisch M (2008) Risk 
factors for squamous cell carcinoma of the penis–population-based case-
control study in Denmark. Cancer Epidemiol Biomark Prev a Publ Am 
Assoc Cancer Res Cosponsored Am Soc Prev Oncol 17:2683–2691
Morris BJ, Wodak AD, Mindel A, Schrieber L, Duggan KA, Dilley A et al (2012) 
The 2010 Royal Australasian College of Physicians’ policy statement 
‘Circumcision of infant males’ is not evidence based. Intern Med J 
42:822–828
Narayana AS, Olney LE, Loening SA, Weimar GW, Culp DA (1982) Carcinoma of 
the penis. Analysis of 219 cases. Cancer 49:2185–2191
National Cancer Institute (2010) Surveillance, Epidemiology, and End Results 
Program, vol. 2014. http://seer.cancer.gov/resources/. Accessed 11 May 
2014
Ng M, Freeman MK, Fleming TD, Robinson M, Dwyer-Lindgren L, Thomson 
B et al (2014) Smoking prevalence and cigarette consumption in 187 
countries, 1980–2012. JAMA 311:183–192
Office of National Statistics (2014) England and Wales Cancer Registry Data, vol 
2014. http://www.ons.gov.uk/ons/index.html. Accessed 11 May 2014
Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 
2:533–543
Parkin DM, Muir CS (1992) Cancer incidence in five continents. Comparability 
and quality of data. IARC Sci Publ (120):45–173
Parkin DM, Sitas F, Chirenje M, Stein L, Abratt R, Wabinga H (2008) Part I: cancer 
in indigenous Africans–burden, distribution, and trends. Lancet Oncol 
9:683–692
Pizzocaro G, Algaba F, Horenblas S, Solsona E, Tana S, Van Der Poel H et al 
(2010) EAU penile cancer guidelines 2009. Eur Urol 57:1002–1012
Richters J, Smith AM, de Visser RO, Grulich AE, Rissel CE (2006) Circumcision 
in Australia: prevalence and effects on sexual health. Int J STD AIDS 
17:547–554
Rickwood AM, Kenny SE, Donnell SC (2000) Towards evidence based circumci-
sion of English boys: survey of trends in practice. BMJ 321:792–793
Royal Australasian College of Physicians ICHD (2010) Circumcision of infant 
males. https://www.racp.edu.au/page/paed-policy. Accessed 11 May 
2014
Schoen EJ, Oehrli M, Colby C, Machin G (2000) The highly protective effect of 
newborn circumcision against invasive penile cancer. Pediatrics 105:E36
Segi M, Fujisaku S, Kurihara M (1957) Geographical observation on cancer 
mortality by selected sites on the basis of standardised death rate. Gan 
Gann Jpn J Cancer Res 48:219–225
Society AC (2011) Global cancer facts & figures, 2nd edn. American Cancer 
Society, Atlanta
Spilsbury K, Semmens JB, Wisniewski ZS, Holman CD (2003) Routine circumci-
sion practice in Western Australia 1981-1999. ANZ J Surg 73:610–614
Svoboda JS, Van Howe RS (2013) Out of step: fatal flaws in the latest AAP 
policy report on neonatal circumcision. J Med Ethics 39:434–441
Tsen HF, Morgenstern H, Mack T, Peters RK (2001) Risk factors for penile cancer: 
results of a population-based case-control study in Los Angeles County 
(United States). Cancer Causes Control CCC 12:267–277
Wabinga HR, Parkin DM, Wabwire-Mangen F, Nambooze S (2000) Trends in 
cancer incidence in Kyadondo County, Uganda, 1960–1997. Br J Cancer 
82:1585–1592
West R, Zatonski W, Przewozniak K, Jarvis MJ (2007) Can we trust national 
smoking prevalence figures? Discrepancies between biochemically 
assessed and self-reported smoking rates in three countries. Cancer 
Epidemiol Biomark Prev a Publ Am Assoc Cancer Res Cosponsored Am 
Soc Prev Oncol 16:820–822
WHO/UNAIDS technical consultation (2007) Male circumcision for HIV preven-
tion: research implications for policy and programming. Conclusions and 
recommendations (excerpts). Reprod Health Matters 15:11–14
Wolbarst A (1932) Circumcision and penile cancer. The Lancet 219:150–153
